HESH(301103.SZ)

Last Updated 00:00:00
longbridge loading

Zhaoke Ophthalmology Narrows Core Loss as Revenue Halves in 2025

Tip Ranks·
SH
512010
+0.58%
SZ
301103
-3.10%
SZ
159992
+0.89%
Tip Ranks·
SH
512010
+0.58%
SZ
301103
-3.10%
SZ
159992
+0.89%

HESH released its performance for the first three quarters, with a net profit attributable to the parent company of 54.3953 million yuan, an increase of 232.18%

Zhitong·
SZ
301103
-3.10%
Zhitong·
SZ
301103
-3.10%

HESH plans to grant 6.37 million shares of restricted stock

Zhitong·
SZ
301103
-3.10%
Zhitong·
SZ
301103
-3.10%

Ophthalmology medical concept stocks surged, SPAS hit the daily limit in the afternoon

Zhitong·
SZ
003020
-2.79%
SZ
301096
+3.29%
SH
688050
+0.98%
Zhitong·
SZ
003020
-2.79%
SZ
301096
+3.29%
SH
688050
+0.98%

HESH: In the first half of 2025, the net profit was 44.3246 million yuan, a year-on-year increase of 84.19%

Zhitong·
SZ
301103
-3.10%
Zhitong·
SZ
301103
-3.10%

HESH: The company has not signed any agency or cooperation agreements with any artificial cornea companies in Japan

Zhitong·
SZ
301103
-3.10%
Zhitong·
SZ
301103
-3.10%

HESH: Advanced Manufacturing Fund plans to reduce its holdings of the company's shares by no more than 2%

Zhitong·
SZ
301103
-3.10%
Zhitong·
SZ
301103
-3.10%

The smart medical sector opened high, with PR rising over 8%

Zhitong·
SZ
301230
+0.26%
SZ
301103
-3.10%
Zhitong·
SZ
301230
+0.26%
SZ
301103
-3.10%

HESH released its first-quarter performance, with a net profit attributable to the parent company of 32.5319 million yuan, an increase of 12.27%

Zhitong·
SZ
301103
-3.10%
Zhitong·
SZ
301103
-3.10%

HESH: Termination of the cross-border e-commerce project of Hainan HESH Jingcai Trading Co., Ltd

Zhitong·
SZ
301103
-3.10%
Zhitong·
SZ
301103
-3.10%
© 2026 Longbridge｜Disclaimer